SEC Form 4 · accession 0000898432-19-000375
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis S. Waldman
Officer — Controller
Period of report
Mar 7, 2019
Accepted (ET)
Mar 11, 2019 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 7, 2019 | A | 15,000 | $9.84 | A | 17,005 | D | |
| Common StockF1 | Mar 7, 2019 | S | 15,000 | $24.2736 | D | 2,005 | D | |
| Common Stock | holding | — | — | — | 25,000 | I | By Louis Waldman Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $9.84 | Mar 7, 2019 | M | 15,000 | D | — | Dec 14, 2024 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $24.25 to $24.365. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This option was granted on 12/15/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.